Open AccessEfficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
Author(s) -
Andrew Blauvelt,
Craig L. Leonardi,
Melinda Gooderham,
Kim Papp,
Sandra Philipp,
Jashin J. Wu,
Atsuyuki Igarashi,
Mary Flack,
Ziqian Geng,
Tianshuang Wu,
Anne Camez,
David Williams,
Richard Langley
Publication year - 2020
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2020.0723
Subject(s) - medicine , psoriasis area and severity index , erythema , placebo , psoriasis , randomized controlled trial , severity of illness , physical therapy , gastroenterology , surgery , dermatology , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom